VERTEX PHARMACEUTICALS INC / MA Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year
VERTEX PHARMACEUTICALS INC / MA (VRTX) had Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year of $20.60 million as of 2024-09-30, per its 10-Q filed 2024-11-05.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear · last filed 2024-11-05
- 2024-09-30: Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year $20.60M.
- 2019-09-30: Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year $2.30M.
- 2019-06-30: Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year $4.83M.
- 2019-03-31: Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year $7.33M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year |
|---|---|
| 2024-09-30 | $20.60M 10-Q · filed 2024-11-05 |
| 2019-09-30 | $2.30M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $4.83M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $7.33M 10-Q · filed 2019-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |